Threshold Pharmaceuticals (THLD) Reports Q3 Loss of 8c/Share
Get Alerts THLD Hot Sheet
Join SI Premium – FREE
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) reported Q3 loss of ($0.08), $0.07 better than the analyst estimate of ($0.15).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share